维普期刊资源整合服务平台（V6.5）

260篇 您的检索式：作者名="SCHAER"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Time-course of quantitative urinary leukocytes and bacteria counts during antibiotic therapy in women with symptoms of urinary tract infection显示文摘	Cornelia Ottiger Gabriel Schaer Andreas R. Huber	2007	Clinica Chimica Acta2007，，1：	2
2	对扩张型心肌病患者预防性植入埋藏式心脏复律除颤器对左室功能的影响显示文摘Background: The value of an implantable cardioverter defibrillator(ICD) for primary prevention in dilated cardiomyopathy(DCM) is unclear, as randomized trials could not show a survival benefit compared to drug therapy. It has not been investigated if patients with a very poor left ventricular function(LVEF) could profit from an ICD. Methods: Consecutive patients with DCM who received an ICD between December 1996 and November 2003 were included in this analysis. Patients were divided in group A(secondary prevention) and group B(primary prevention). Both groups were stratified in subgroups with left ventricular ejection fraction(LVEF) below and above 20% . Results: Fifty eight patients were included(male 50, age 56.4± 12.7 years). Follow-up was 34± 19 months. There was no difference regarding death(18% vs. 11% ), but significant differences(p value< 0.05) regarding any adverse events(55% vs. 22% ), any ICD intervention(48% vs. 17% ) and ICD interventions for life-threatening arrhythmias(27% vs. 0% )between group A and B. LVEF was not predictive for events in group A, whereas in group B only patients with a LVEF< 20% had events(p value 0.02). Over time there was an increase of the LVEF of more than 15% determined by echocardiography in 36% of patients, significantly more often in group B. Conclusions: Indication for primary prevention with an ICD in DCM should be made with caution. Larger studies are needed to determine if patients with LVEF of< 20% might benefit from an ICD.	Schaer B. A. Ammann P. Sticherling C. 黄浙勇(译) 任付先(校)	2006	世界核心医学期刊文摘(心脏病学分册)2006，2，8：	1
3	Defective adhesion in tumor infiltrating CD8+T cells显示文摘	Koneru M Monu N Schaer D	2006	J Immunol2006，176，10：	1
4	Comparison of animal discs used in disc research to human lumbar disc显示文摘	Beckstein JC Sounok S Schaer TP		0，，1976：	1
5	Defective proximal TCR sig- naling inhibits CD8+mmor-infiltrating lymphocyte lytic function显示文摘	Koneru M Schaer D Monu N	2005	j Immunol2005，174，4：	1
6	Microfiltration of colloids and natural organic matter 显示文摘	Schaer A I Schwicker U Fischer M M	2000	J Membr Sci2000，171，2：	1
7	Close connection between improve- ment in left ventricular function by cardiac resynchronization therapy and the in- cidence of m'rhythmias in cardiac resynchronization therapy-defibrillation or pa- tients显示文摘	Schaer BA Osswald S Valenino M	2010	Eur J Heart Fail2010，12，12：	1
8	An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure显示文摘	Penn MS Mendelsohn FO Schaer GL	2013	Circ Res2013，112，5：	1
9	Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation显示文摘	KUHNE M SCHAER B AMMANN P	2010	Swiss Med Wkly2010，140，：	1
10	Norepinephrine alone versus norepinephrine plus low-dose dopamine:enhanced renal blood flow with combination pressor therapy显示文摘	Schaer GL Fink MP Parrillo JE		0，，：	1
11	Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome 显示文摘	Schaer DJ Schleiffenbau m B Kurrer M	2005	Eur J Haematol2005，74，1：	1
12	Som- atostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-se- lective ligands显示文摘	Reubi JC Waser B Schaer JC	2001	Eur J Nucl Med2001，28，7：	1
13	Constitu tive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin显示文摘	SCHAER C A SCHOEDON G IMHOF A	2006	Circ Res2006，99，9：	1
14	Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring显示文摘	IMHOF A SCHAER DJ SCHANZ U	2006	Swiss Med Wkly2006，136，4546：	1
15	Suppression of the reninangiotensin system by intravenous digoxin inchronic congestive heart failure显示文摘	Covit AB Schaer GL Sealey JE	1983	Am J Med1983，75，3：	1
16	Effects of doping in polymer light-emitting diodes显示文摘	ROMERO D B SCHAER M ZUPPIRELI L	1995	Appl Phys Lett1995，67，12：	1
17	Holter monitoring for syncope:diagnostic yield in different patient groups and impact on device implantation显示文摘	Kulme M Schaer B Moulay N	2007	US National Library of Medicine National Institutes of Health2007，100，12：	1
18	Neurological adverseevents to voriconazole: evidence for therapeutic drug monitoring显示文摘	Imhof A Schaer DJ4 Schanz U	2006	Swiss Med Wkly2006，136，4546：	1
19	Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome 显示文摘	Gothelf D Schaer M Eliez S	2008	Dev Disabil Res Rev2008，14，1：	1
20	Vascular endothelial growth factor(VEGF)levels as a tool to discriminate between malignant and nonmalignant ascites显示文摘	Nascimento I Schaer R Lemaire D		0，，：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示